Gene · 3635
Papers3,499
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,499
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neutrophil Activated by the Famous and Potent PMA (Phorbol Myristate Acetate). | Cells | 2022 | 36139464 | PubTator, text mining | PubMed |
| Single-cell analysis of gene expression in the substantia nigra pars compacta of a pesticide-induced mouse model of Parkinson's disease. | Transl Neurosci | 2022 | 36117858 | PubTator, text mining | PubMed |
| Insulin Resistance and Type 2 Diabetes Mellitus: An Ultimatum to Renal Physiology. | Cureus | 2022 | 36111327 | PubTator, text mining | PubMed |
| Alzheimer's Disease Polygenic Risk Score Is Not Associated With Cognitive Decline Among Older Adults With Type 2 Diabetes. | Front Aging Neurosci | 2022 | 36110429 | PubTator, text mining | PubMed |
| A review of brain imaging biomarker genomics in Alzheimer's disease: implementation and perspectives. | Transl Neurodegener | 2022 | 36109823 | PubTator, text mining | PubMed |
| Akt isoforms in the immune system. | Front Immunol | 2022 | 36081513 | PubTator, text mining | PubMed |
| Identification of Src Family Kinases as Potential Therapeutic Targets for Chemotherapy-Resistant Triple Negative Breast Cancer. | Cancers (Basel) | 2022 | 36077757 | PubTator, text mining | PubMed |
| Modulation of Glycoprotein VI and Its Downstream Signaling Pathways as an Antiplatelet Target. | Int J Mol Sci | 2022 | 36077280 | PubTator, text mining | PubMed |
| Simultaneous Targeting of Multiple oncomiRs with Phosphorothioate or PNA-Based Anti-miRs in Lymphoma Cell Lines. | Pharm Res | 2022 | 36071352 | PubTator, text mining | PubMed |
| Exosome application in treatment and diagnosis of B-cell disorders: leukemias, multiple sclerosis, and arthritis rheumatoid. | Cell Mol Biol Lett | 2022 | 36064322 | PubTator, text mining | PubMed |
| Pathogenesis, therapeutic strategies and biomarker development based on "omics" analysis related to microglia in Alzheimer's disease. | J Neuroinflammation | 2022 | 36058959 | PubTator, text mining | PubMed |
| microRNA expression in acute myeloid leukaemia: New targets for therapy? | EJHaem | 2022 | 36051053 | PubTator, text mining | PubMed |
| Spatial organization and early signaling of the B-cell receptor in CLL. | Front Immunol | 2022 | 36016925 | PubTator, text mining | PubMed |
| Antibody-Dependent Enhancement: ″Evil″ Antibodies Favorable for Viral Infections. | Viruses | 2022 | 36016361 | PubTator, text mining | PubMed |
| Encapsulation of miRNA and siRNA into Nanomaterials for Cancer Therapeutics. | Pharmaceutics | 2022 | 36015246 | PubTator, text mining | PubMed |
| Expression of MicroRNAs in Sepsis-Related Organ Dysfunction: A Systematic Review. | Int J Mol Sci | 2022 | 36012630 | PubTator, text mining | PubMed |
| Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer's Disease: Towards a Personalized Polypharmacology Patient-Centered Approach. | Int J Mol Sci | 2022 | 36012569 | PubTator, text mining | PubMed |
| The Immunomodulatory Role of Hypoxic Tumor-Derived Extracellular Vesicles. | Cancers (Basel) | 2022 | 36010994 | PubTator, text mining | PubMed |
| MicroRNAs and the Diagnosis of Childhood Acute Lymphoblastic Leukemia: Systematic Review, Meta-Analysis and Re-Analysis with Novel Small RNA-Seq Tools. | Cancers (Basel) | 2022 | 36010971 | PubTator, text mining | PubMed |
| MicroRNA-155 acts as an anti-inflammatory factor in orbital fibroblasts from Graves' orbitopathy by repressing interleukin-2-inducible T-cell kinase. | PLoS One | 2022 | 35980936 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3635/papers?page=26